Product Detail

1. Plan strategies to reduce and eliminate catheter-associated urinary tract infections, surgical site infections, ventilator associated and non-ventilator-associated pneumonias and central-line-associated bloodstream infections.
2. Explain best practices for treatment and control of multi-drug resistant microorganisms, including MRSA, Clostridium difficile, VRE, ESBL and CRE.
3. Evaluate the newest vaccine recommendations for healthcare workers and children.
4. Distinguish between mosquito-borne illnesses of Dengue, Chikungunya, and Zika, which may be a threat to the United States.
5. Discuss the latest treatments available for HIV/AIDS, as well as pre-exposure prophylaxis.
6. Explain the medications available that “cure” Hepatitis C.
7. Compare the current recommendations to control and treat tuberculosis.

Cutting-Edge Strategies for Infection Control: Improve Staff Compliance

• Handwashing
• Disinfection
• Donning and Removing Personal Protective Equipment (PPEs)
• Immunizations (Influenza, Tdap, Pneumonia, etc.)

Eliminate/Prevent/Reduce:

• Catheter-Associated Urinary Tract Infections
• Surgical Site Infections
• Ventilator-Associated Pneumonias
• Central-Line Associated Bloodstream Infections
• Influenza Outbreaks in Healthcare (Hospitals, Long-Term Care, etc.)

New Immunizations Guidelines:

• Children/Adolescents
• Adults
• Healthcare Personnel

Vaccine Preventable Diseases are Back

• Pertussis (Whooping Cough)
• Measles

Influenza Update:

• Vaccination
• Treatments
• Prophylaxis
• Infection Control Protocols
• Seasonal vs. Pandemics

CDC, APIC, SHEA, IDSA Guidelines to Control Multi-Drug Resistant Organisms

• MRSA (Community- or Healthcare-Associated)
• VRE (Vancomycin-Resistant Entococcus)
• Daptomycin-Resistant
• Enterococcus
• ESBL (Extended Spectrum Beta-Lactamase Organisms)
• Resistant Klebisella and E. Coli
• Acinetobacter
• CRE (Carbapenem-resistant Enterobacteriaceae)
• “Very” Resistant Klebisella and E. Coli
• Clostridium Difficile
• New Treatments

Emerging Infectious Diseases: Exotic to the Common!

• Chagas Disease (New Threat for USA?)
• Return of SARS
• Emergence of MERS
• Creutzfeldt Jakob Disease & v Creutzfeldt
• Jakob Disease (Mad Cows)
• Meningococcal Disease
• Bacterial vs. Fungal vs. Viral
• Meningitis
• West Nile Virus
• Tickborne Diseases
• Ebola-Lassa Fevers
• Foodborne Illness (How Common):
• E. Coli O157-H7
• Salmonella
• Listeria
• Campylobacter
• Vibrio
• Norovirus

Updates for Bloodborne Pathogens and Tuberculosis:

• Hepatitis B:
  • Protocols for Immunizations
  • Healthcare Personnel
  • Children-Adolescents
  • Diabetics!
  • Approved Treatments for Chronic Hepatitis B
  • Outbreaks of Hepatitis B and C in Healthcare
  • Protocols for Occupational Exposures

• Hepatitis C:
  • Risk Groups and Factors
  • New Effective Treatments
  • Changes for Interferon
  • Protocols for Occupational Exposures HIV/AIDS:
  • “Confirmed Cured Patient”
  • The Science Behind “The Cured Patient”
  • New “One” Pill a Day Treatment
  • Prophylaxis for High-Risk Groups
  • Possible Eradication of HIV-AIDS
  • Protocols for Occupational Exposures

• Tuberculosis:
  • Blood Test Instead of Skin Testing for Exposure-Latency
  • IGRA (Interferon Gamma Release Assays)
  • New Treatment Protocols for TB
  • New Prophylaxis Regimen
  • Infection Control Protocols for TB

William "Barry" Inman has 40 years of experience as an epidemiologist, working for a busy health department in Florida. In his current role, Barry is responsible for control of communicable diseases through surveillance and investigation methods, working directly with the infection control personnel in hospitals, long-term care, acute long-term care, and NASA. He advises concerning appropriate precautions/management strategies and assists infectious disease physicians in the diagnosis of uncommon or exotic diseases by working as a liaison between the Department of Health in Florida and the CDC.

Barry has vast experience in outbreak mitigation and prevention, whether within a healthcare facility, in the community or on a cruise ship. His expertise has been sought for a variety of outbreaks, including: rubella, influenza, legionnaire's disease, measles, pertussis, norovirus and multi-drug resistant microorganism (MRSA, CRE, ESBL). Numerous awards have been bestowed upon Barry for his contributions to minimize the effects of constantly evolving infectious diseases.
Speaker Disclosures:
Financial: William "Barry" Inman has employment relationships with Brevard County Health Department, Circles of Care, Brevard Community College, Circles of Care, and Health First Inc. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: William "Barry" Inman is a member of the Association of Practitioners of Infection Control, the Association of Practitioners of Infection Control Local Chapter 45, and the Florida Practitioners of Infection Control.

Save time and $10 off the price of other submission methods – purchase & take the CE test online for $9.99 USD per participant. Additional processing fees apply for other submission methods (i.e. mail, fax, etc.). Please contact our Customer Service at 1-800-844-8260 for more details.

Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Please note, your state licensing board dictates whether self study is an acceptable form of continuing education. Please refer to your state rules and regulations.

Certificates of Successful Completion are available for email, download and/or printing from your online account immediately following the successful completion of the post-test/evaluation.

**Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of mental health professionals. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your professions standards.

All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners. For speaker disclosures, please see the faculty biography.

---

Nurses/Nurse Practitioners/Clinical Nurse Specialists - Credit Expired: 10/13/2019
No CE available for this board.

California Nurses: PESI, Inc. is a provider approved by the California Board of Registered Nursing, Provider #:17118 for 6.0 self-study contact hours.

You will need to provide your license number to PESI. PESI must have this number on file in order for your hours to be valid.

Florida Nurses: PESI, Inc. is an approved provider by the Florida Board of Nursing. Provider #: FBN2858. These materials qualify for 6.0 self-study contact hours.

New York Infectious Diseases: PESI, Inc. provider identification number IC128, is an approved provider who has been authorized to offer the mandated course work in barrier precautions and infection control measures. This entire course qualifies for credit under this requirement.

Iowa Nurses: PESI, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Nurses successfully completing these self-study materials will earn 7.2 self-study contact hours.

Copies of the evaluation may be sent to the IBON. You will need to provide your license number to PESI. PESI must have this number on file in order for your hours to be valid.

---

Pharmacology Nurse Practitioners
This self-study program offers 60 instructional minutes of pharmacology content which is designed to qualify for 1.0 contact hours toward your pharmacology requirement.

---

Other Professions
This self-study activity qualifies for 6.0 clock hours of instructional content as required by many national, state and local licensing boards and professional organizations. Retain your certificate of completion and contact your board or organization for specific filing requirements.

Disclaimer: **Information obtained in this course should be used within your scope of practice.
**It is your ethical responsibility to report accurate hours to your licensing board.
**All self-study participants must complete and pass (80% or better) a post-test and evaluation prior to receiving a certificate of completion. If you require a copy of the test/evaluation for CE purposes, please print at the time you take the test. Or you may call our customer service department and a copy of your test/evaluation will be emailed to you. Please allow 30-45 days.

Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, Respiratory Care Practitioners